Altimmune, Inc. short interest in 2026
In 2026, Altimmune, Inc.'s disclosed short interest ran from 25.33% of shares outstanding on 15 Jan 2026 to 26.60% on 15 Sep 2026, a change of +1.27 percentage points. The year's high was 27.25% on 30 Apr 2026 and its low 19.35% on 15 May 2026, averaging 23.52% across 17 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 15.38 days on 15 Sep 2026. Full history: Altimmune, Inc..
Cite this page
By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2026 in figures
- Start of year
- 25.33% (15 Jan 2026)
- End of year
- 26.60% (15 Sep 2026)
- Change
- +1.27 pp
- High
- 27.25% (30 Apr 2026)
- Low
- 19.35% (15 May 2026)
- Average
- 23.52%
- Highest days to cover
- 15.38 (15 Sep 2026)
- SEC filings marked
- 6
Every report in 2026
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2026 | 25.33% | 4.24 | |
| 30 Jan 2026 | 23.18% | 3.50 | |
| 13 Feb 2026 | 24.11% | 7.24 | |
| 27 Feb 2026 | 19.60% | 9.97 | |
| 13 Mar 2026 | 20.36% | 6.96 | results (8-K), 10-K filed |
| 31 Mar 2026 | 22.49% | 7.65 | |
| 15 Apr 2026 | 22.09% | 13.71 | |
| 30 Apr 2026 | 27.25% | 4.93 | |
| 15 May 2026 | 19.35% | 11.02 | 10-Q filed, results (8-K) |
| 29 May 2026 | 20.12% | 14.46 | |
| 15 Jun 2026 | 21.56% | 14.57 | |
| 30 Jun 2026 | 24.49% | 8.07 | |
| 15 Jul 2026 | 24.81% | 12.52 | |
| 31 Jul 2026 | 26.71% | 11.45 | |
| 14 Aug 2026 | 26.20% | 11.04 | 10-Q filed, results (8-K) |
| 31 Aug 2026 | 25.56% | 11.84 | |
| 15 Sep 2026 | 26.60% | 15.38 |
See also: Altimmune, Inc.'s full history · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.